Thus, developing strategies that elicit a sufficiently large number of long-lived T EM cells that are not only cytolytic, but also polyfunctional (defined as being able to produce high levels of anti-viral cytokines IFN-γ, TNF, and IL-2) represents a key challenge for next generation vaccines that are able to confer protection against respiratory viruses.